Fox Chase Cancer Center Listed a New Clinical Trial to Study CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

Press/Media

PeriodAug 12 2022

Media coverage

1

Media coverage

  • TitleFox Chase Cancer Center Listed a New Clinical Trial to Study CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date08/12/22
    PersonsAnthony J. Olszanski